181 related articles for article (PubMed ID: 10799747)
1. Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity.
Altmann KH; Wartmann M; O'Reilly T
Biochim Biophys Acta; 2000 May; 1470(3):M79-91. PubMed ID: 10799747
[No Abstract] [Full Text] [Related]
2. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
[TBL] [Abstract][Full Text] [Related]
3. Tumor-killer made; how does it work?
Service RF
Science; 1996 Dec; 274(5295):2009. PubMed ID: 8984658
[No Abstract] [Full Text] [Related]
4. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag DM; McQueney PA; Zhu J; Hensens O; Koupal L; Liesch J; Goetz M; Lazarides E; Woods CM
Cancer Res; 1995 Jun; 55(11):2325-33. PubMed ID: 7757983
[TBL] [Abstract][Full Text] [Related]
5. Chemical synthesis and biological properties of pyridine epothilones.
Nicolaou KC; Scarpelli R; Bollbuck B; Werschkun B; Pereira MM; Wartmann M; Altmann KH; Zaharevitz D; Gussio R; Giannakakou P
Chem Biol; 2000 Aug; 7(8):593-9. PubMed ID: 11048950
[TBL] [Abstract][Full Text] [Related]
6. Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B.
Chou TC; Zhang XG; Balog A; Su DS; Meng D; Savin K; Bertino JR; Danishefsky SJ
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9642-7. PubMed ID: 9689134
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, structure proof, and biological activity of epothilone cyclopropanes.
Johnson J; Kim SH; Bifano M; DiMarco J; Fairchild C; Gougoutas J; Lee F; Long B; Tokarski J; Vite G
Org Lett; 2000 Jun; 2(11):1537-40. PubMed ID: 10841473
[TBL] [Abstract][Full Text] [Related]
8. On the total synthesis and preliminary biological evaluations of 15(R) and 15(S) aza-dEpoB: a Mitsunobu inversion at C15 in pre-epothilone fragments.
Stachel SJ; Chappell MD; Lee CB; Danishefsky SJ; Chou TC; He L; Horwitz SB
Org Lett; 2000 Jun; 2(11):1637-9. PubMed ID: 10841498
[TBL] [Abstract][Full Text] [Related]
9. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB
Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923
[TBL] [Abstract][Full Text] [Related]
10. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.
Hood KA; West LM; Rouwé B; Northcote PT; Berridge MV; Wakefield SJ; Miller JH
Cancer Res; 2002 Jun; 62(12):3356-60. PubMed ID: 12067973
[TBL] [Abstract][Full Text] [Related]
11. A common pharmacophore for cytotoxic natural products that stabilize microtubules.
Ojima I; Chakravarty S; Inoue T; Lin S; He L; Horwitz SB; Kuduk SD; Danishefsky SJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4256-61. PubMed ID: 10200249
[TBL] [Abstract][Full Text] [Related]
12. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)).
Kowalski RJ; Giannakakou P; Hamel E
J Biol Chem; 1997 Jan; 272(4):2534-41. PubMed ID: 8999970
[TBL] [Abstract][Full Text] [Related]
13. Synthetic chemistry. Cancer drugs better than taxol?
Cowden CJ; Paterson I
Nature; 1997 May; 387(6630):238-9. PubMed ID: 9153384
[No Abstract] [Full Text] [Related]
14. Synthesis and biological evaluation of highly potent analogues of epothilones B and D.
Altmann KH; Bold G; Caravatti G; Flörsheimer A; Guagnano V; Wartmann M
Bioorg Med Chem Lett; 2000 Dec; 10(24):2765-8. PubMed ID: 11133086
[TBL] [Abstract][Full Text] [Related]
15. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone.
Wang M; Xia X; Kim Y; Hwang D; Jansen JM; Botta M; Liotta DC; Snyder JP
Org Lett; 1999 Jul; 1(1):43-6. PubMed ID: 10822530
[TBL] [Abstract][Full Text] [Related]
16. The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice.
Chou TC; O'Connor OA; Tong WP; Guan Y; Zhang ZG; Stachel SJ; Lee C; Danishefsky SJ
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):8113-8. PubMed ID: 11438750
[TBL] [Abstract][Full Text] [Related]
17. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells.
Giannakakou P; Gussio R; Nogales E; Downing KH; Zaharevitz D; Bollbuck B; Poy G; Sackett D; Nicolaou KC; Fojo T
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2904-9. PubMed ID: 10688884
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of epothilones A and B in solid and solution phase.
Nicolaou KC; Winssinger N; Pastor J; Ninkovic S; Sarabia F; He Y; Vourloumis D; Yang Z; Li T; Giannakakou P; Hamel E
Nature; 1997 May; 387(6630):268-72. PubMed ID: 9153390
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 12,13-cyclopropyl and 12,13-cyclobutyl epothilones.
Nicolaou KC; Namoto K; Li J; Ritzén A; Ulven T; Shoji M; Zaharevitz D; Gussio R; Sackett DL; Ward RD; Hensler A; Fojo T; Giannakakou P
Chembiochem; 2001 Jan; 2(1):69-75. PubMed ID: 11828429
[No Abstract] [Full Text] [Related]
20. Myxobacterial bounty.
Mann J
Nature; 1997 Jan; 385(6612):117. PubMed ID: 8990108
[No Abstract] [Full Text] [Related]
[Next] [New Search]
